Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Drug Information » FDA Approved Drugs » 1996
Medical Areas: Pulmonary/Respiratory Diseases | Family Medicine | Infections and Infectious Diseases

View By:YearCompanyConditionsTherapeutic AreasDrug Names

Tavist (clemastine fumarate)

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: Sandoz Pharmaceuticals
Approval Status: Approved November 1996
Treatment Area: cold symptoms, including sneezing and runny nose

General Information

Tavist-D has been approved for the treatment of cold symptoms, including sneezing and runny nose. The FDA decision results from well-controlled clinical studies of the antihistamine clemastive fumarate, the active ingredient that differentiates the Tavist product from others.